Katherine A High - Net Worth and Insider Trading
Katherine A High Net Worth
The estimated net worth of Katherine A High is at least $24 Million dollars as of 2024-03-28. Katherine A High is the See Remarks of Spark Therapeutics Inc and owns about 210,000 shares of Spark Therapeutics Inc (ONCE) stock worth over $24 Million. Details can be seen in Katherine A High's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Katherine A High has not made any transactions after 2017-11-28 and currently still holds the listed stock(s).
Transaction Summary of Katherine A High
Katherine A High Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Katherine A High owns 3 companies in total, including CRISPR Therapeutics AG () , Incyte Corp () , and Spark Therapeutics Inc () .
Click here to see the complete history of Katherine A High’s form 4 insider trades.
Insider Ownership Summary of Katherine A High
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CRISPR Therapeutics AG | 2019-06-11 | director | |
Incyte Corp | 2020-03-26 | director | |
Spark Therapeutics Inc | 2019-12-17 | director & See Remarks |
Katherine A High Latest Holdings Summary
Katherine A High currently owns a total of 1 stock. Katherine A High owns 210,000 shares of Spark Therapeutics Inc (ONCE) as of November 28, 2017, with a value of $24 Million.
Latest Holdings of Katherine A High
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ONCE | Spark Therapeutics Inc | 2017-11-28 | 210,000 | 113.57 | 23,849,700 |
Holding Weightings of Katherine A High
Katherine A High Form 4 Trading Tracker
According to the SEC Form 4 filings, Katherine A High has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 5,000 shares on November 28, 2017, which brought Katherine A High around $356,600.
Insider Trading History of Katherine A High
- 1
Katherine A High Trading Performance
Katherine A High Ownership Network
Ownership Network List of Katherine A High
Ownership Network Relation of Katherine A High
Katherine A High Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Katherine A High is the director of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Financial Officer Raju Prasad , Chief Business Officer Samarth Kulkarni , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG () Insider Trades Summary
Over the past 18 months, Katherine A High made no insider transaction in CRISPR Therapeutics AG (). Other recent insider transactions involving CRISPR Therapeutics AG () include a net sale of 330,755 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 140,139 shares of CRISPR Therapeutics AG () in total and bought 0 shares, with a net sale of 140,139 shares. During the past 18 months, 340,139 shares of CRISPR Therapeutics AG () were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,139 shares.
CRISPR Therapeutics AG ()'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Katherine A High Mailing Address
Above is the net worth, insider trading, and ownership report for Katherine A High. You might contact Katherine A High via mailing address: 3737 Market Street, Suite 1300, Philadelphia Pa 19104.